Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An inducible genetic tool for tracking and manipulating specific microglial states in development and disease

ABSTRACT: An inducible genetic tool for tracking and manipulating specific microglial states in development and disease

PROVIDER: PRJNA1103143 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

An inducible genetic tool for tracking and manipulating specific microglial states in development and disease

Project description:Recent single-cell RNA sequencing studies have revealed distinct microglial states in development and disease. These include proliferative region-associated microglia (PAM) in developing white matter and disease-associated microglia (DAM) prevalent in various neurodegenerative conditions. PAM and DAM share a similar core gene signature and other functional properties. However, the extent of the dynamism and plasticity of these microglial states, as well as their functional significance, remains elusive, partly due to the lack of specific tools. Here, we report the generation of an inducible Cre driver line, Clec7a-CreERT2, designed to target PAM and DAM in the brain parenchyma. Utilizing this tool, we isolate and profile labeled cells during development and in several disease models, uncovering convergence and context-dependent differences in PAM/DAM gene expression. Through long-term tracking, we demonstrate surprising levels of plasticity in these microglial states. Lastly, we specifically deplete DAM in cuprizone-induced demyelination, revealing their roles in disease progression and recovery.

2024-06-11 | GSE264553 | GEO

An inducible genetic tool for tracking and manipulating specific microglial states in development and disease.

Project description:Recent single-cell RNA sequencing studies have revealed distinct microglial states in development and disease. These include proliferative region-associated microglia (PAM) in developing white matter and disease-associated microglia (DAM) prevalent in various neurodegenerative conditions. PAM and DAM share a similar core gene signature and other functional properties. However, the extent of the dynamism and plasticity of these microglial states, as well as their functional significance, remains elusive, partly due to the lack of specific tools. Here, we report the generation of an inducible Cre driver line, Clec7a-CreERT2, designed to target PAM and DAM in the brain parenchyma. Utilizing this tool, we profile labeled cells during development and in several disease models, uncovering convergence and context-dependent differences in PAM/DAM gene expression. Through long-term tracking, we demonstrate surprising levels of plasticity in these microglial states. Lastly, we specifically depleted DAM in cuprizone-induced demyelination, revealing their roles in disease progression and recovery.

| S-EPMC10723357 | biostudies-literature

A comparative analysis of microglial inducible Cre lines

Project description:We investigated the effects of tamoxifen, CreER recombination, and genetic manipulations to genes whose promoters are used to driving CreER expression on microglial gene expression across 4 different microglial inducible Cre lines.

2023-08-24 | GSE217062 | GEO

A comparative analysis of microglial inducible Cre lines

Project description:A comparative analysis of microglial inducible Cre lines

| PRJNA896641 | ENA

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization.

Project description:A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization.

| PRJNA836550 | ENA

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization II.

Project description:A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization II.

| PRJNA841984 | ENA

Ubiquiton – an inducible, linkage-specific polyubiquitylation tool

Project description:Here we introduce a set of engineered ubiquitin protein ligases and matching ubiquitin acceptor tags for the rapid, inducible linear (M1-), K48-, or K63-linked polyubiquitylation of proteins in yeast and mammalian cells. By applying the so-called ‘Ubiquiton’ (Ubo) system to proteasomal targeting and the endocytic pathway, we validate this tool for soluble cytoplasmic and nuclear as well as chromatin-associated and integral membrane proteins and demonstrate how it can be used to control the localization and stability of its targets. SILAC-based and label-free quantitative proteomics experiments were performed to verify the linkages of the polyubiquitin chains produced on a model substrate, GFP, in yeast and to identify potential off-target effects of a transgenic E3 system in human cells.

2023-12-15 | PXD045662 | Pride

Ubiquiton – an inducible, linkage-specific polyubiquitylation tool

2023-12-15 | PXD046526 | Pride

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization.

Project description:Human microglia play a pivotal role in neurological diseases, but few targeted therapies that directly modulate microglial state or function exist due to an incomplete understanding of microglial heterogeneity. We use single-cell RNA sequencing to profile live human microglia from autopsies or surgical resections across diverse neurological diseases and central nervous system regions. We observe a central divide between oxidative and heterocyclic metabolism and identify subsets associated with antigen presentation, motility, and proliferation. Specific subsets are enriched in susceptibility genes for neurodegenerative diseases or the disease-associated microglial signature. We validate subtypes in situ with an RNAscope-immunofluorescence pipeline and leverage our dataset as a classification resource, finding that iPSC model systems recapitulate substantial in vivo heterogeneity. Finally, we identify and validate candidates for chemically inducing subtype-specific states in vitro, showing that Camptothecin downregulates the transcriptional signature of disease-enriched subsets and upregulates a signature previously shown to be depleted in Alzheimer’s.

2024-10-18 | GSE202556 | GEO

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization II.

2024-10-18 | GSE204702 | GEO